BlackRock Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$231,763
-34.0%
88,798
-9.4%
0.00%
Q2 2023$350,947
+79.5%
98,030
+9.3%
0.00%
Q1 2023$195,483
-84.7%
89,671
-15.3%
0.00%
Q4 2022$1,273,976
+92.4%
105,900
+3.6%
0.00%
Q3 2022$662,000
+3.9%
102,199
-26.5%
0.00%
Q2 2022$637,000
-96.0%
139,052
-92.4%
0.00%
Q1 2022$15,832,000
-28.9%
1,830,166
+17.4%
0.00%
-100.0%
Q4 2021$22,257,000
-29.4%
1,558,607
+8.7%
0.00%0.0%
Q3 2021$31,508,000
+85.5%
1,433,548
+12.9%
0.00%
Q2 2021$16,986,000
+2028.6%
1,269,530
+1516.0%
0.00%
Q1 2021$798,000
+173.3%
78,560
+14.3%
0.00%
Q4 2020$292,000
+25.9%
68,735
-22.8%
0.00%
Q3 2020$232,000
-8.7%
89,001
+23.5%
0.00%
Q2 2020$254,000
+81.4%
72,038
+56.6%
0.00%
Q1 2020$140,000
-53.0%
45,996
-20.5%
0.00%
Q4 2019$298,000
+30.7%
57,836
-19.3%
0.00%
Q3 2019$228,000
-14.6%
71,629
-3.6%
0.00%
Q2 2019$267,000
+2.3%
74,291
+3.4%
0.00%
Q1 2019$261,000
+25.5%
71,868
+3.6%
0.00%
Q4 2018$208,000
+46.5%
69,343
+137.2%
0.00%
Q3 2018$142,000
-32.1%
29,229
+4.2%
0.00%
Q2 2018$209,00028,0410.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders